Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.59p
   
  • Change Today:
    -0.023p
  • 52 Week High: 3.96
  • 52 Week Low: 1.17
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 5,559,012
  • Market Cap: £21.27m
  • RiskGrade: 340

Regulatory News

Final Results 25-Apr-2024 07:00 RNS
Total Voting Rights 28-Mar-2024 07:00 RNS
Placing to Raise US$4.2 million 29-Feb-2024 07:00 RNS
CBR Brain Delivery 16-Feb-2024 07:00 RNS
CBR Intranasal Delivery 14-Feb-2024 07:00 RNS
FDA Consents to Phase I Trials of HEMO-CAR-T 09-Feb-2024 07:00 RNS
Approval and Issuance of U.S. Conditioning Patent 02-Feb-2024 07:00 RNS
Submission of Complete Response to Clinical Hold 16-Jan-2024 07:00 RNS
HEMO-CAR-T Process Qualification Run Completed 08-Jan-2024 07:00 RNS
Placing to Raise £534,375 28-Nov-2023 12:19 RNS
CBR Expanded to Treatment of Cancer 27-Nov-2023 07:00 RNS
Lentivirus Re-manufacturing Completed 15-Nov-2023 07:00 RNS
Total Voting Rights 31-Oct-2023 07:00 RNS
Half-year Report 28-Sep-2023 12:28 RNS
Strategic Investment from Prevail Partners, LLC 18-Sep-2023 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.59p
Change Today -0.023p
% Change -1.43 %
52 Week High 3.96
52 Week Low 1.17
Volume 5,559,012
Shares Issued 1,341.82m
Market Cap £21.27m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.45% below the market average48.45% below the market average48.45% below the market average48.45% below the market average48.45% below the market average
69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average
Price Trend
23.35% below the market average23.35% below the market average23.35% below the market average23.35% below the market average23.35% below the market average
43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
16:08 9 @ 1.60p
16:07 491 @ 1.60p
16:06 99,259 @ 1.57p
16:05 100,000 @ 1.57p
16:04 100,000 @ 1.57p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page